Search Results

chemokine receptor system is implicated in a wide range of inflammatory, autoimmune and infectious diseases a single receptor as patients cannot be stratified into CKRs specific subpopulations for a specific disease the majority of potential therapeutic applications are situated in the area of chronic inflammatory disease

Repurposing Vaptans "Men with advanced prostate cancer are treated by androgen deprivation therapy but the disease cancer patient sample data revealed that coexpression of AVPR1A and AVPR2 is highly correlated with disease

August 2022 "Aims: The pathophysiological mechanism(s) underlying non-alcoholic fatty liver disease (

pharmaceutical sector, from new pipelines targeting obesity to significant collaborations in cardiometabolic disease Volume II invites experts to deepen our collective understanding of GPCR pathways in health and disease

global biopharmaceutical company developing novel oral therapeutics to treat a wide range of chronic diseases

receptor (GPCR) GPR35 is involved in oncogenic signaling, bacterial infections, and inflammatory bowel disease transducer interactions and allow for mechanism-based therapies against, for example, inflammatory bowel disease

for developing therapeutic agents that target specific receptor dimer states to modulate signaling in diseases Perreault, M.L., et al., Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease

in multiple sclerosis patients Multiple sclerosis (MS) is a specific type of chronic immune-mediated disease Despite intensive research, a known treatment for MS disease yet to be introduced. Thus, the development of novel and safe medications needs to be considered for the disease management

CCXI), a biopharmaceutical company focused on orally administered therapeutics to treat autoimmune diseases

UdM”), to discover novel small molecules targeting G-Protein Coupled Receptors (GPCRs) in a metabolic disease

NETs were also detected in thrombotic lesions in several disease backgrounds, pointing towards a role between platelets and NETs and the potential of this alliance to influence the course of inflammatory diseases

structural approach Mechanisms controlling haemolymph circulation under resting conditions in the chagas disease , and more Class B1 GPCRs: Insights into Multi-Receptor Pharmacology for the Treatment of Metabolic Disease

modulator VU0486846 reduces neurogliosis in female Alzheimer's mice The association of GNB5 with Alzheimer disease of GPR139 in the medial septum ameliorates cognitive impairment in two mouse models of Alzheimer's disease

regulation of B2R, which shed light on structure-based drug design for the treatment of B2R-related diseases

novel mechanism providing diversity to receptor function and play important roles in physiology and disease

Sir William Osler Scientists have long sought to discover a “golden bullet” that would cure every disease The more we know about the pathology of diseases, the more complicated it is to modulate them by a specific

advanced our understanding of rod outer segment (ROS) morphology and the pathological basis of retinal diseases

D2LR, D3R, and D4R, vasopressin V1AR, and serotonin 5-HT1AR are noted in various neurodegenerative diseases antagonism, kurarinone might be a potential compound that can alleviate clinical symptoms of Parkinson's disease

Commercialization of Voyager’s GBA1 Program and Other Next-Generation Gene Therapies for Neurological Diseases Manager Director of Molecular Pharmacology, Discovery Biology Staff Scientist/Senior Staff Scientist, Disease

Schizophrenia Sphingosine 1-phosphate receptor subtype 1 (S1P1) activity in the course of Alzheimer's disease

sites of GPCRs for drug discovery Targeting mGluR group III for the treatment of neurodegenerative diseases Methods & Updates in GPCR Research Advancements in the use of xenopus oocytes for modelling neurological disease

Heptares and Lilly Enter Multi-target Collaboration and License Agreement in Diabetes and Metabolic Diseases Trial of INV-202, an Oral, Peripherally-acting CB1 Inverse Agonist, in Patients with Diabetic Kidney Disease

Promising preclinical data supports the applicability of CB2 activation in autoimmune and inflammatory diseases

fundraising gives us the means to achieve our ambitions: to become a leading player in the field of brain diseases

Promising preclinical data support the applicability of CB2 activation in autoimmune and inflammatory diseases

significance in GPCR internalization dynamics, internalization routes, postinternalization fates, and related diseases

Neuroscience Diverse signaling mechanisms and heterogeneity of astrocyte reactivity in Alzheimer's disease Sosei Heptares and Kallyope Nominate First GPCR Target for Therapeutic Development in Gastrointestinal Diseases

The levels of chemerin in circulation are correlated with certain disease conditions, such as patients

contribute to the implementation of the guidelines, together improving translation from in vitro to disease-relevant

important drug targets, and numerous drugs that modulate GPCRs are already in clinical use for various diseases Drug repurposing: AI algorithms can screen existing drugs and repurpose them for GPCR-related diseases By analyzing drug-target interactions and disease pathways, AI can identify potential candidates that Towards a comprehensive understanding of GPCRs, ligands, diseases, and their associations: open-access